Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 7,321–7,380 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

Shanghai Municipal Hospital of Traditional Chinese Medicine1 Shanghai Public Health Clinical Center1 Shanghai Punan Hospital of Pudong New District Ethics Committee1 Shanghai Second Rehabilitation Hospital1 Shanghai Stroke Service System1 Shanghai University of Sport1 Shanghai University of Traditional Chinese Medicine1 Shanghai Yangzhi Rehabilitation Centre1 Shanxi Bethune Hospital Ethics Committee1 Shanxi Cancer Hospital1 Shanxi Provincial Children’s Hospital1 Shanxi Provincial People’s Hospital1 Shaoxing Maternal and Child Health Hospital1 Shapingba Hospital1 Shawlands Academy1 Sheba Medical Centre1 Sheffield ASPIRE registry1 Sheffield Centre for Health and Related Research1 Sheffield Children’s NHS Foundation Trust1 Sheffield Children’s National Health Service Foundation Trust1 Sheffield Diagnostic Genetics Service1 Sheffield Hallam University1 Sheffield Neurology Unit1 Sheffield Sleep House1 Sheffield Teaching Hospital1 Sheffield Teaching Hospital NHS Trust1 Sheffield Teaching Hospitals NHS Foundation Trust1 Sheikh Shakhbout Medical City1 Sheikh Zayed Hospital1 Shelton Hospital1 Shenzhen Eye Hospital1 Shenzhen People’s Hospital1 Shenzhen University General Hospital1 Shepherd Vascular1 Sherwood Forest Hospitals1 Sheyang Mini Birth Cohort Study1 Shields et al1 Shifa International Hospital1 Shifa Tameer-e-Millat University1 Shin et al1 Shing et al1 Shinpu-kai Tamashima Chuo Hospital1 Shockwave Medical1 Shoe4Africa Children’s Hospital1 Shunyi1 Sichuan Academy of Medical Sciences1 Sichuan Provincial People’s Hospital1 Sichuan University West China Hospital1 Sidney Kimmel Comprehensive Cancer Center1 Sidney Kimmel NCI-Designated Comprehensive Cancer Center1 Siemens 3.0T PRISMA1 Siemens Atellica1 Siemens Healthineers AG1 Sierra Leone Ministry of Health1 Sigma Aldrich1 Signatera™1 Simpson et al1 Sinai Health1 SingHealth Centralised Institutional Review Board1 SingHealth Diabetes Registry1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 225 of 946

P.047 Cytokine profile of individuals with raynaud’s phenomenon with and without systemic sclerosis

jsrd · abstract · 2026-06-05 · 2 matching annotations

89.9%

Helsinki University Hospital Division of Rheumatology rheumatic connective tissue diseases systemic sclerosis Raynaud’s phenomenon (RP)

…: For patients who came to NVC at the Division of Rheumatology, Helsinki University Hospital, from June 2013 to March 2014, medical records were reviewed 10…

P.061 Triple-negative systemic sclerosis: epidemiological profile and implications for pathogenesis from the spring registry

jsrd · abstract · 2026-06-05 · 2 matching annotations

82.6%

SPRING registry cyclophosphamide systemic sclerosis (SSc)azathioprine Systemic sclerosis interstitial lung disease (ILD)corticosteroids Interstitial lung disease

…evalence of triple-negative patients in the Italian multicenter SPRING registry (Systemic sclerosis Progression INvestiGation) and to character…

P.070 Prevalence of venous thromboembolism in patients with scleroderma: a comparative study

jsrd · abstract · 2026-06-05 · 2 matching annotations

92.4%

Meir Medical Center scleroderma anticoagulant therapy cancer anticoagulation therapy anticoagulants

…scleroderma patients followed at the Rheumatology Department of Meir Medical Center. Patients meeting inclusion criteria were matched with four con…

P.074 Prognostic value of telangiectasia score in systemic sclerosis: a retrospective cohort study from a tertiary center

jsrd · abstract · 2026-06-05 · 2 matching annotations

89.1%

Coimbra Local Health Unit Department of Rheumatology pulmonary hypertension systemic sclerosis systemic sclerosis (SSc)interstitial lung disease (ILD)digital ulcers telangiectasias SSc

…4 patients with SSc followed at the Department of Rheumatology, Coimbra Local Health Unit. All patients underwent a semiquantitative telangiectasia score…

P.110 Lung transplant outcomes in patients with myositis- and systemic sclerosis-associated interstitial lung disease compared to idiopathic pulmonary fibrosis: a multicenter retrospective analysis

jsrd · abstract · 2026-06-05 · 2 matching annotations

94.0%

Vancouver General Hospital Centre Hospitalier de l’Universite de Montreal idiopathic pulmonary fibrosis systemic sclerosis SSc idiopathic inflammatory myopathies IIM overlap myositis interstitial lung disease (ILD)

…with IIM, SSc, or IPF who underwent lung transplantation at the Vancouver General Hospital and at the Centre Hospitalier de l’Universite de Montreal ILD c…

P.118 Detecting interstitial lung disease and identifying extended disease on chest computed tomography in patients with systemic sclerosis: cut-offs for lung texture analysis and its prognostic implication

jsrd · abstract · 2026-06-05 · 2 matching annotations

92.8%

University Hospital Zurich Careggi University Hospital Florence systemic sclerosis (SSc)Interstitial lung disease (ILD)SSc-ILD ILD

…d Methods SSc patients visiting the Rheumatology Departments of University Hospital Zurich and the Careggi University Hospital Florence were included. Tec…

P.120 Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease (SSc-ILD): results from an EUSTAR cohort study

jsrd · abstract · 2026-06-05 · 2 matching annotations

85.9%

EUSTAR mycophenolate mofetil tocilizumab rituximab nintedanib Interstitial lung disease (ILD)systemic sclerosis (SSc)SSc-ILD MMF

… (95%CI -4.49, 2.97) for RTX vs combination.Conclusions In this EUSTAR cohort analysis, treatment of SSc-ILD patients with MMF, RTA or…

P.129 Macitentan for pulmonary arterial hypertension associated with systemic sclerosis: results from the European Scleroderma trials and research group (EUSTAR) database

jsrd · abstract · 2026-06-05 · 2 matching annotations

82.9%

EUSTAR Macitentan macitentan-treated pulmonary arterial hypertension (PAH)Systemic Sclerosis (SSc)SSc-PAH

…clinical outcomes of macitentan-treated SSc-PAH patients in the EUSTAR cohort.Material and Methods Adult SSc patients recorded in the …

P.136 Concentration of anti-centromere-antibodies associates with and may predict development of pulmonary arterial hypertension

jsrd · abstract · 2026-06-05 · 2 matching annotations

77.0%

tertiary referral center Biosynex systemic sclerosis (SSc)ACA Pulmonary arterial hypertension (PAH)ACA-positive

…nts fulfilling the 2013 classification criteria followed at our tertiary referral center during a 25-year time period. PAH was diagnosed by right heart …

P.137 Longitudinal changes in high-sensitivity cardiac troponin T and their association with clinical outcomes in systemic sclerosis: a cohort study

jsrd · abstract · 2026-06-05 · 2 matching annotations

90.6%

Scleroderma Clinic Khon Kaen University systemic sclerosis SSc coronary artery disease

…ial and Methods We conducted a cohort study using data from the Scleroderma Clinic, Khon Kaen University, Thailand (2013-2023). Eligible patients …

P.145 Common proteomic biomarkers of vascular and myocardial tissue abnormalities in systemic sclerosis and rheumatoid arthritis

jsrd · abstract · 2026-06-05 · 2 matching annotations

77.6%

CONVAS ELCASA rheumatoid arthritis Systemic sclerosis atherosclerotic cardiovascular disease

…are shared.Material and Methods Seventy-eight participants from CONVAS (‘CONnective Tissue Disease and VASculitis Cohort’) and ELCASA …

P.164 Evaluating gastrointestinal involvement in systemic sclerosis using the GIT 2.0 instrument and the impact of immunosuppressive therapy in a Chinese cohort

jsrd · abstract · 2026-06-05 · 2 matching annotations

94.8%

Peking Union Medical College Hospital University of California, Los Angeles mycophenolate mofetil tofacitinib tocilizumab rituximab methotrexate upadacitinib systemic sclerosis (SSc)MTX+1 more

…s GI outcomes.Material and Methods We enrolled outpatients from Peking Union Medical College Hospital between October 2024 and August 2025. Baseline data, including …